News
We came across a bearish thesis on DaVita Inc. (NYSE:DVA) on ValueInvestorsClub by Fenkell. In this article, we will ...
In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in his early days, permitting an 11th-hour delay of an uncontroversial vaccine ...
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
19h
Live Science on MSNOzempic in a pill? New oral drug may work as well as Ozempic-style injectablesThe drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...
Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...
Investigators studied the prevalence and outcomes of venous thromboembolic events (VTEs) among hospitalized patients with and without CKD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results